Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intestinal and liver toxicity of antineoplastic drugs.

Literature DB >> 6375139

Intestinal and liver toxicity of antineoplastic drugs.

Abstract

This discussion was selected from the weekly Grand Rounds in the Department of Medicine, University of Washington, Seattle. Taken from a transcription, it has been edited by Drs Paul G. Ramsey, Assistant Professor of Medicine, and Philip J. Fialkow, Professor and Chairman of the Department of Medicine.

Entities: Disease Gene

Mesh：

Substances：
Antineoplastic Agents

Year: 1984 PMID： 6375139 PMCID： PMC1021607

Source DB: PubMed Journal: West J Med ISSN： 0093-0415

150 in total

1. Subcutaneous fat necrosis with acute hemorrhagic pancreatitis-a case in a child with steroid-resistant nephrosis treated with 6-mercaptopurine.

Authors: E Heuser; E Lieberman; G N Donnell; B H Landing
Journal: Calif Med Date: 1967-01

2. Candida infection of the gastrointestinal tract.

Authors: P Eras; M J Goldstein; P Sherlock
Journal: Medicine (Baltimore) Date: 1972-09 Impact factor: 1.889

3. Acute pancreatitis as a complication of Imuran therapy in regional enteritis.

Authors: J R Nogueira; M A Freedman
Journal: Gastroenterology Date: 1972-05 Impact factor: 22.682

4. A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotheray with cis-platinum.

Authors: A J Jacobs; G Deppe; C J Cohen
Journal: Gynecol Oncol Date: 1980-08 Impact factor: 5.482

5. The interaction of drug and radiation effects on normal tissues.

Authors: T L Phillips; K K Fu
Journal: Int J Radiat Oncol Biol Phys Date: 1978 Jan-Feb Impact factor: 7.038

6. Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood.

Authors: N J Gwavava; C R Pinkerton; J F Glasgow; J M Sloan; J M Bridges
Journal: J Clin Pathol Date: 1981-07 Impact factor: 3.411

7. PTG, a new antineoplastic epipodyphyllotoxin.

Authors: P J Creaven; L M Allen
Journal: Clin Pharmacol Ther Date: 1975-08 Impact factor: 6.875

8. Hydroxylation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) by rat liver microsomes.

Authors: H E May; R Boose; D J Reed
Journal: Biochem Biophys Res Commun Date: 1974-03-25 Impact factor: 3.575

9. Hepatic veno-occlusive disease after high-dose mitomycin C and autologous bone marrow transplantation therapy.

Authors: M R Gottfried; O Sudilovsky
Journal: Hum Pathol Date: 1982-07 Impact factor: 3.466

10. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.

Authors: S Frytak; C G Moertel; J R O'Fallon; J Rubin; E T Creagan; M J O'Connell; A J Schutt; N W Schwartau
Journal: Ann Intern Med Date: 1979-12 Impact factor: 25.391

9 in total

Review 1. Antineoplastic drugs in 1990. A review (Part II).

Authors: D J Black; R B Livingston
Journal: Drugs Date: 1990-05 Impact factor: 9.546

Review 2. Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group.

Authors: Sharon Castellino; Andrew Muir; Ami Shah; Sheila Shope; Kevin McMullen; Kathy Ruble; Ashley Barber; Andrew Davidoff; Melissa M Hudson
Journal: Pediatr Blood Cancer Date: 2010-05 Impact factor: 3.167

Intestinal and liver toxicity of antineoplastic drugs.

1. Subcutaneous fat necrosis with acute hemorrhagic pancreatitis-a case in a child with steroid-resistant nephrosis treated with 6-mercaptopurine.

2. Candida infection of the gastrointestinal tract.

3. Acute pancreatitis as a complication of Imuran therapy in regional enteritis.

4. A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotheray with cis-platinum.

5. The interaction of drug and radiation effects on normal tissues.

6. Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood.

7. PTG, a new antineoplastic epipodyphyllotoxin.

8. Hydroxylation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) by rat liver microsomes.

9. Hepatic veno-occlusive disease after high-dose mitomycin C and autologous bone marrow transplantation therapy.

10. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.

Review 1. Antineoplastic drugs in 1990. A review (Part II).

Review 2. Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group.

Review 3. Types, causes, and therapies of hepatitis occurring in liver transplant recipients.

4. Chemotherapy induced liver abnormalities: an imaging perspective.

5. Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients.

Review 6. Imaging of complications of oncological therapy in the gastrointestinal system.

Review 7. Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors.

Review 8. The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity.

9. Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis.